BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30312500)

  • 1. Development and validation of the McGill body image concerns scale for use in head and neck oncology (MBIS-HNC): A mixed-methods approach.
    Rodriguez AM; Frenkiel S; Desroches J; De Simone A; Chiocchio F; MacDonald C; Black M; Zeitouni A; Hier M; Kost K; Mlynarek A; Bolster-Foucault C; Rosberger Z; Henry M
    Psychooncology; 2019 Jan; 28(1):116-121. PubMed ID: 30312500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a Novel, Multidomain Head and Neck Cancer Appearance- and Function-Distress Patient-Reported Outcome Measure.
    Graboyes EM; Hand BN; Ellis MA; Huang AT; Nilsen ML; Pipkorn P; Marsh CH; Maurer S; Day TA; Sterba KR
    Otolaryngol Head Neck Surg; 2020 Nov; 163(5):979-985. PubMed ID: 32482151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of body image measures for people diagnosed with head and neck cancer (HNC).
    Shunmuga Sundaram C; Dhillon HM; Butow PN; Sundaresan P; Rutherford C
    Support Care Cancer; 2019 Oct; 27(10):3657-3666. PubMed ID: 31203508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent structure and reliability analysis of the measure of body apperception: cross-validation for head and neck cancer patients.
    Jean-Pierre P; Fundakowski C; Perez E; Jean-Pierre SE; Jean-Pierre AR; Melillo AB; Libby R; Sargi Z
    Support Care Cancer; 2013 Feb; 21(2):591-8. PubMed ID: 22886430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Dutch version of the Swallowing Quality-of-Life Questionnaire (DSWAL-QoL) and the adjusted DSWAL-QoL (aDSWAL-QoL) using item analysis with the Rasch model: a pilot study.
    Simpelaere IS; Van Nuffelen G; De Bodt M; Vanderwegen J; Hansen T
    Health Qual Life Outcomes; 2017 Apr; 15(1):66. PubMed ID: 28388899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need for supportive care among head and neck cancer patients: psychometric assessment of the Dutch version of the Supportive Care Needs Survey Short-Form (SCNS-SF34) and the newly developed head and neck cancer module (SCNS-HNC).
    Jansen F; Witte BI; van Uden-Kraan CF; Braspenning AM; Leemans CR; Verdonck-de Leeuw IM
    Support Care Cancer; 2016 Nov; 24(11):4639-49. PubMed ID: 27318479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using classical test theory, item response theory, and Rasch measurement theory to evaluate patient-reported outcome measures: a comparison of worked examples.
    Petrillo J; Cano SJ; McLeod LD; Coon CD
    Value Health; 2015 Jan; 18(1):25-34. PubMed ID: 25595231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Modular Health-Related Quality of Life Instrument for Electronic Assessment and Treatment Monitoring: Web-Based Development and Psychometric Validation of Core Thrive Items.
    Wicks P; McCaffrey S; Goodwin K; Black R; Hoole M; Heywood J
    J Med Internet Res; 2019 Jan; 21(1):e12075. PubMed ID: 30681962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel, Disease-Specific Self-Report Instrument to Measure Body Image Concerns in Patients With Head and Neck Skin Cancer.
    Beal BT; White EK; Behera AK; McGuinness AE; Zavell AE; Blangger H; Armbrecht ES; Maher IA
    Dermatol Surg; 2018 Jan; 44(1):17-24. PubMed ID: 28877154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Canadian Version of the Shame and Stigma Scale for Head and Neck Cancer Patients.
    Bobevski I; Kissane DW; Desroches J; De Simone A; Henry M
    Curr Oncol; 2023 Aug; 30(8):7553-7565. PubMed ID: 37623029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Head and Neck Cancer Treatment on Survivors' Mealtime Experience.
    Chan KMK; Chan HKW; Siu JYL; Pu D; Nund RL; Ward EC
    Laryngoscope; 2019 Jul; 129(7):1572-1578. PubMed ID: 30284283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-Cultural Translation, Adaptation and Reliability of the Danish M. D. Andeson Dysphagia Inventory (MDADI) in Patients with Head and Neck Cancer.
    Hajdú SF; Plaschke CC; Johansen C; Dalton SO; Wessel I
    Dysphagia; 2017 Aug; 32(4):472-479. PubMed ID: 28271296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial.
    Vaccarino AL; Kalali AH; Blier P; Gilbert Evans S; Engelhardt N; Foster JA; Frey BN; Greist JH; Kobak KA; Lam RW; MacQueen G; Milev R; Müller DJ; Parikh SV; Placenza FM; Rizvi SJ; Rotzinger S; Sheehan DV; Sills T; Soares CN; Turecki G; Uher R; Williams JBW; Kennedy SH; Evans KR
    Innov Clin Neurosci; 2020 Jul; 17(7-9):30-40. PubMed ID: 33520402
    [No Abstract]   [Full Text] [Related]  

  • 14. [Development and validation of the Chinese version of modified body imgae scale in Chinese population].
    Gao XX; Zhu L; Yu SJ; Xu T
    Zhonghua Fu Chan Ke Za Zhi; 2018 Feb; 53(2):88-91. PubMed ID: 29534376
    [No Abstract]   [Full Text] [Related]  

  • 15. Establishing Reliability and Validity of the FACE-Q Craniofacial Module for Pediatric Head and Neck Cancer.
    Wang Y; Rae C; Tsangaris E; Nathan PC; Bouffet E; Dix D; Wong Riff K; Klassen A
    J Adolesc Young Adult Oncol; 2024 Apr; 13(2):307-315. PubMed ID: 37852001
    [No Abstract]   [Full Text] [Related]  

  • 16. Further refinement of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure using classical test theory and item response theory.
    Pattinson R; Trialonis-Suthakharan N; Pickles T; Austin J; FitzGerald A; Augustin M; Bundy C
    Br J Dermatol; 2024 Apr; 190(5):718-728. PubMed ID: 38064666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Brazilian version of the Shame and Stigma Scale (SSS-Br) for patients with head and neck cancers.
    Pirola WE; Paiva BSR; de Oliveira CZ; Lucchetti G; Lucchetti ALG; Kissane D; Paiva CE
    Palliat Support Care; 2020 Apr; 18(2):186-192. PubMed ID: 31317847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging patient-reported outcomes data to inform oncology clinical decision making: Introducing the FACE-Q Head and Neck Cancer Module.
    Cracchiolo JR; Klassen AF; Young-Afat DA; Albornoz CR; Cano SJ; Patel SG; Pusic AL; Matros E
    Cancer; 2019 Mar; 125(6):863-872. PubMed ID: 30500993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring financial toxicity incurred after treatment of head and neck cancer: Development and validation of the Financial Index of Toxicity questionnaire.
    Hueniken K; Douglas CM; Jethwa AR; Mirshams M; Eng L; Hope A; Chepeha DB; Goldstein DP; Ringash J; Hansen A; Martino R; Li M; Liu G; Xu W; de Almeida JR
    Cancer; 2020 Sep; 126(17):4042-4050. PubMed ID: 32603521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supportive care among head and neck cancer patients: An initial validation of the Dutch version of the Performance Status Scale for Head and Neck Cancer (D-PSS-HN).
    Baudelet M; Van den Steen L; Wouters S; De Bodt M; Vanderveken O; Duprez F; Van Nuffelen G
    Int J Lang Commun Disord; 2023; 58(5):1668-1679. PubMed ID: 37189297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.